CIK: 0001792126 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value ($000): $853,604 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IDYA | IDEAYA BIOSCIENCES INC | 3,900,000 | $70,863 | 8.3% | $17.02 | -1.1% | COM | 45166A102 |
| APLS | APELLIS PHARMACEUTICALS INC | 1,350,000 | $69,809 | 8.2% | $51.35 | +3.3% | COM | 03753U106 |
| CYTK | CYTOKINETICS INC | 1,500,000 | $68,730 | 8.1% | $28.97 | +48.3% | COM NEW | 23282W605 |
| IMVT | IMMUNOVANT INC | 3,150,000 | $55,913 | 6.6% | $12.59 | 0.0% | COM | 45258J102 |
| — | ALLAKOS INC | 5,286,666 | $44,514 | 5.2% | $6.12 | — | COM | 01671P100 |
| BCYC | BICYCLE THERAPEUTICS PLC | 1,435,000 | $42,476 | 5.0% | $27.16 | — | SPONSORED ADS | 088786108 |
| XENE | XENON PHARMACEUTICALS INC | 900,000 | $35,487 | 4.2% | $36.16 | +0.7% | COM | 98420N105 |
| — | IVERIC BIO INC | 1,500,000 | $32,115 | 3.8% | $17.94 | — | COM | 46583P102 |
| — | KARUNA THERAPEUTICS INC | 150,000 | $29,475 | 3.5% | $115.76 | — | COM | 48576A100 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,000,000 | $29,210 | 3.4% | $17.98 | +28.2% | COM | 92790C104 |
| DSGN | DESIGN THERAPEUTICS INC | 2,797,501 | $28,702 | 3.4% | $30.93 | -56.2% | COM | 25056L103 |
| IMCR | IMMUNOCORE HLDGS PLC | 500,000 | $28,535 | 3.3% | $49.98 | — | ADS | 45258D105 |
| SRPT | SAREPTA THERAPEUTICS INC | 220,000 | $28,508 | 3.3% | $73.57 | +57.5% | COM | 803607100 |
| ALXO | ALX ONCOLOGY HLDGS INC | 2,349,600 | $26,480 | 3.1% | $37.43 | -70.0% | COM | 00166B105 |
| DYN | DYNE THERAPEUTICS INC | 2,150,000 | $24,919 | 2.9% | $18.68 | -38.1% | COM | 26818M108 |
| — | AKERO THERAPEUTICS INC | 400,000 | $21,920 | 2.6% | $34.05 | — | COM | 00973Y108 |
| VTYX | VENTYX BIOSCIENCES INC | 657,016 | $21,544 | 2.5% | $17.42 | +70.1% | COM | 92332V107 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 1,400,000 | $20,720 | 2.4% | $19.22 | -9.1% | COM | 03969K108 |
| — | DICE THERAPEUTICS INC | 660,000 | $20,592 | 2.4% | $29.56 | — | COM | 23345J104 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 60,000 | $17,415 | 2.0% | $97.80 | 0.0% | COM | 558868105 |
| RCKT | ROCKET PHARMACEUTICALS INC | 750,000 | $14,678 | 1.7% | $18.42 | 0.0% | COM | 77313F106 |
| FULC | FULCRUM THERAPEUTICS INC | 2,000,000 | $14,560 | 1.7% | $13.82 | -52.8% | COM | 359616109 |
| — | ASTRIA THERAPEUTICS INC | 864,960 | $12,879 | 1.5% | $14.89 | — | COM | 04635X102 |
| COGT | COGENT BIOSCIENCES INC | 1,100,000 | $12,716 | 1.5% | $12.39 | 0.0% | COM | 19240Q201 |
| GERN | GERON CORP | 4,000,000 | $9,680 | 1.1% | $2.24 | +0.0% | COM | 374163103 |
| OLMA | OLEMA PHARMACEUTICALS INC | 3,743,875 | $9,172 | 1.1% | $46.89 | -93.8% | COM | 68062P106 |
| — | FIBROGEN INC | 525,000 | $8,411 | 1.0% | $16.02 | — | COM | 31572Q808 |
| — | CEREVEL THERAPEUTICS HLDNG I | 260,000 | $8,200 | 1.0% | $31.54 | — | COM | 15678U128 |
| — | CYMABAY THERAPEUTICS INC | 1,250,000 | $7,838 | 0.9% | $6.27 | — | COM | 23257D103 |
| ANAB | ANAPTYSBIO INC | 250,000 | $7,748 | 0.9% | $28.24 | 0.0% | COM | 032724106 |
| — | REATA PHARMACEUTICALS INC | 180,000 | $6,838 | 0.8% | $37.99 | — | CL A | 75615P103 |
| VERA | VERA THERAPEUTICS INC | 285,000 | $5,515 | 0.6% | $18.11 | 0.0% | CL A | 92337R101 |
| — | PROMETHEUS BIOSCIENCES INC | 50,000 | $5,500 | 0.6% | $110.00 | — | COM | 74349U108 |
| — | RAPT THERAPEUTICS INC | 200,000 | $3,960 | 0.5% | $19.80 | — | COM | 75382E109 |
| — | MORPHOSYS AG | 900,000 | $3,222 | 0.4% | $3.58 | — | SPONSORED ADS | 617760202 |
| — | VIGIL NEUROSCIENCE INC | 188,390 | $2,355 | 0.3% | $7.03 | — | COM | 92673K108 |
| — | SPRUCE BIOSCIENCES INC | 1,000,000 | $1,097 | 0.1% | $4.46 | — | COM | 85209E109 |
| TYRA | TYRA BIOSCIENCES INC | 110,856 | $843 | 0.1% | $19.11 | -63.0% | COM | 90240B106 |
| LIANY | LIANBIO | 280,000 | $459 | 0.1% | $6.16 | — | SPONSORED ADS | 53000N108 |
| — | NUVATION BIO INC | 66,666 | $10 | 0.0% | $2.67 | — | *W EXP 07/07/202 | 67080N119 |